menu toggle
As we continue to evolve our brand to Cencora, you will continue to see visual changes. We will be sunsetting amerisourcebergen.com over time and are actively moving content and information over to cencora.com. Please visit cencora.com if you can't find what you are looking for here.
Visit Cencora

Podcast: Conversations around interchangeability and biosimilar entries in new therapeutic categories

By AmerisourceBergen

Launches in ophthalmology and the first interchangeable insulin biosimilar in the U.S.  bring new opportunities for this exciting product class. Listen in as our experts discuss these developments. 

You can also listen and subscribe wherever you get your podcasts, like Apple or Spotify.

Continue the conversation

Learn more about our solutions for this important product category.
Topics:
Biosimilars Affordability Market access Regulatory

Related Content

Manufacturers

Education: The centerpiece of biosimilar adoption

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2023
Biosimilars adoption

Manufacturers

Podcast: Milestones for biosimilars in 2022 and looking ahead to 2023

Inverted color AmerisourceBergen icon
AmerisourceBergen
July 2022
Biosimilars podcast

Manufacturers

Webinar: Bracing for the Impact of Biosimilars: Navigating Terrain in the U.S. Market Landscape

AB-TB-Sq-Block
FormularyDecisions
May 2024
Chemical chain